Search research articles
Contact Us
Filters
Showing results (51-60 of 147) with videos related to
Page
of 15
Sort By:
Science Translational Medicine
|
November 16, 2022
Protein kinase Cι mediates immunosuppression in lung adenocarcinoma
Ning Yin, Yi Liu, Capella Weems, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2024
Comprehensive profiling of cancer neoantigens from aberrant RNA splicing
Daniel P Wickland, Colton McNinch, Erik Jessen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles
Lupe G Salazar, John Fikes, Scott Southwood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 10, 2013
The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine
Kevin D Pavelko, Michael P Bell, Lavakumar Karyampudi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming
Yushe Dang, Keith L Knutson, Vivian Goodell, et al.
Oncoimmunology
|
July 30, 2013
Toward understanding the genetics of regulatory T cells in ovarian cancer
Melissa S Derycke, Bridget Charbonneau, Claudia C Preston, et al.
Cancer Immunology, Immunotherapy : CII
|
February 9, 2010
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
Brian M Olson, Thomas P Frye, Laura E Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2002
Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines
Mary L Disis, Theodore A Gooley, Kristine Rinn, et al.
Cancer Immunology Research
|
July 4, 2014
Association studies of Fcγ receptor polymorphisms with outcome in HER2+ breast cancer patients treated with trastuzumab in NCCTG (Alliance) Trial N9831
Nadine Norton, Rebecca M Olson, Mark Pegram, et al.
Cancer Research
|
April 15, 2014
Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody
Lavakumar Karyampudi, Purushottam Lamichhane, Adam D Scheid, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 147) with videos related to
Sort By:
Page
of 15
Science Translational Medicine
|
November 16, 2022
Protein kinase Cι mediates immunosuppression in lung adenocarcinoma
Ning Yin, Yi Liu, Capella Weems, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2024
Comprehensive profiling of cancer neoantigens from aberrant RNA splicing
Daniel P Wickland, Colton McNinch, Erik Jessen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2003
Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles
Lupe G Salazar, John Fikes, Scott Southwood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 10, 2013
The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine
Kevin D Pavelko, Michael P Bell, Lavakumar Karyampudi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming
Yushe Dang, Keith L Knutson, Vivian Goodell, et al.
Oncoimmunology
|
July 30, 2013
Toward understanding the genetics of regulatory T cells in ovarian cancer
Melissa S Derycke, Bridget Charbonneau, Claudia C Preston, et al.
Cancer Immunology, Immunotherapy : CII
|
February 9, 2010
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
Brian M Olson, Thomas P Frye, Laura E Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2002
Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines
Mary L Disis, Theodore A Gooley, Kristine Rinn, et al.
Cancer Immunology Research
|
July 4, 2014
Association studies of Fcγ receptor polymorphisms with outcome in HER2+ breast cancer patients treated with trastuzumab in NCCTG (Alliance) Trial N9831
Nadine Norton, Rebecca M Olson, Mark Pegram, et al.
Cancer Research
|
April 15, 2014
Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody
Lavakumar Karyampudi, Purushottam Lamichhane, Adam D Scheid, et al.
Page
of 15